• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

68Ga-FAPI 与 18F-FDG PET/CT 对胰腺癌细胞肝转移的影像学比较。

Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases.

机构信息

From the Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University; Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou; and Academician (Expert) Workstation of Sichuan Province, Luzhou, Sichuan, People's Republic of China.

出版信息

Clin Nucl Med. 2021 Jul 1;46(7):589-591. doi: 10.1097/RLU.0000000000003561.

DOI:10.1097/RLU.0000000000003561
PMID:33630809
Abstract

A 65-year-old man with suspected pancreatic cancer underwent 18F-FDG PET/CT for initial staging. Mild FDG uptake was observed in the pancreatic mass and bone destruction in the 10th rib on the right. No significant FDG uptake was seen with the multiple hypodense or isodense nodules in the liver. However, 68Ga-FAPI PET/CT revealed intense FAPI uptake in the pancreas and the 10th rib and multiple lesions in the liver. Finally, a biopsy confirmed carcinoma in the head of the pancreas with liver metastasis. This case highlighted that 68Ga-FAPI may outperform 18F-FDG PET/CT in identifying micrometastases of bones and hidden liver metastases.

摘要

一位 65 岁男性疑似患有胰腺癌,进行 18F-FDG PET/CT 初始分期。在胰腺肿块和右侧第 10 肋骨的骨破坏处观察到轻度 FDG 摄取。在肝脏内的多个低或等密度结节中未见明显的 FDG 摄取。然而,68Ga-FAPI PET/CT 显示在胰腺、第 10 肋骨和肝脏内的多个病变中摄取强烈的 FAPI。最后,活检证实胰头癌伴肝转移。本病例提示 68Ga-FAPI 可能优于 18F-FDG PET/CT 识别骨微转移和隐匿性肝转移。

相似文献

1
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases.68Ga-FAPI 与 18F-FDG PET/CT 对胰腺癌细胞肝转移的影像学比较。
Clin Nucl Med. 2021 Jul 1;46(7):589-591. doi: 10.1097/RLU.0000000000003561.
2
Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.18F-FDG、68Ga-FAPI 和 68Ga-DOTATATE PET/CT 在胰腺神经内分泌肿瘤患者中的比较。
Clin Nucl Med. 2021 Sep 1;46(9):764-765. doi: 10.1097/RLU.0000000000003763.
3
Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.68Ga-DOTA-FAPI-04 PET/CT 肿瘤成像:与 18F-FDG PET/CT 在 22 种不同癌症类型中的比较。
Clin Nucl Med. 2022 Apr 1;47(4):e333-e339. doi: 10.1097/RLU.0000000000004073.
4
68Ga-FAPI PET/CT Imaging of Multiple Muscle Metastases of Pancreatic Cancer.68Ga-FAPI PET/CT 显像在胰腺癌多处肌肉转移中的应用。
Clin Nucl Med. 2022 Jan 1;47(1):73-75. doi: 10.1097/RLU.0000000000003888.
5
Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.18F-FDG PET/CT 与 68Ga-FAPI-04 PET/CT 在胃腺癌分期和再分期中的比较。
Nucl Med Commun. 2022 Jan 1;43(1):64-72. doi: 10.1097/MNM.0000000000001489.
6
Comparison of 18F-FDG and 68Ga-FAPI PET/CT in Gastric Kaposi Sarcoma.18F-FDG与68Ga-FAPI PET/CT在胃卡波西肉瘤中的比较
Clin Nucl Med. 2022 Sep 1;47(9):e596-e599. doi: 10.1097/RLU.0000000000004172. Epub 2022 Apr 5.
7
Comparison of the diagnostic efficacy of  Ga-FAPI-04 PET/MR and F-FDG PET/CT in patients with pancreatic cancer.Ga-FAPI-04 PET/MR 与 F-FDG PET/CT 诊断胰腺癌的效能比较。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2877-2888. doi: 10.1007/s00259-022-05729-5. Epub 2022 Mar 4.
8
Superiority of 68Ga-FAPI-04 in Delineation of Soft Tissue and Liver Metastases in Chromophobe Renal Cell Carcinoma for Restaging.68Ga-FAPI-04在鉴别嫌色性肾细胞癌软组织和肝转移灶用于再分期中的优势
Clin Nucl Med. 2022 Dec 1;47(12):e758-e759. doi: 10.1097/RLU.0000000000004374. Epub 2022 Aug 12.
9
The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG.[68Ga]Ga-FAPI-04 PET/CT在[18F]FDG检查结果为阴性或不明确的原发灶不明患者中的额外作用。
Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1442-1452. doi: 10.1007/s00259-022-06095-y. Epub 2023 Jan 7.
10
Positron emission tomography and computed tomography with [Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer.使用[镓]镓-成纤维细胞活化蛋白抑制剂的正电子发射断层扫描和计算机断层扫描可改善胰腺癌患者的肿瘤检测和分期。
Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1322-1337. doi: 10.1007/s00259-021-05576-w. Epub 2021 Oct 15.

引用本文的文献

1
Value of [F]AlF-NOTA-FAPI-04 PET/CT for predicting pathological response and survival in patients with locally advanced pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherapy.[F]AlF-NOTA-FAPI-04 PET/CT在预测接受新辅助化疗的局部晚期胰腺导管腺癌患者病理反应和生存情况中的价值
Eur J Nucl Med Mol Imaging. 2025 May;52(6):2118-2131. doi: 10.1007/s00259-025-07084-7. Epub 2025 Jan 17.
2
Advancements in early detection of pancreatic cancer: the role of artificial intelligence and novel imaging techniques.胰腺癌早期检测的进展:人工智能和新型成像技术的作用。
Abdom Radiol (NY). 2025 Apr;50(4):1731-1743. doi: 10.1007/s00261-024-04644-7. Epub 2024 Oct 28.
3
Diagnostic Performances of PET/CT Using Fibroblast Activation Protein Inhibitors in Patients with Primary and Metastatic Liver Tumors: A Comprehensive Literature Review.
基于成纤维细胞激活蛋白抑制剂的 PET/CT 对原发性和转移性肝脏肿瘤患者的诊断性能:一项全面的文献综述。
Int J Mol Sci. 2024 Jun 29;25(13):7197. doi: 10.3390/ijms25137197.
4
Allysine-Targeted Molecular MRI Enables Early Prediction of Chemotherapy Response in Pancreatic Cancer.靶向醛赖氨酸的分子磁共振成像能够早期预测胰腺癌的化疗反应。
Cancer Res. 2024 Aug 1;84(15):2549-2560. doi: 10.1158/0008-5472.CAN-23-3548.
5
F-FAPI-04 Outperforms F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma.F-FAPI-04 在胰腺腺癌患者的临床评估中优于 F-FDG PET/CT。
J Nucl Med. 2024 Feb 1;65(2):206-212. doi: 10.2967/jnumed.123.266283.
6
[F] AlF‑NOTA‑FAPI‑04 PET/CT as a promising tool for imaging fibroblast activation protein in gastrointestinal system cancers: a prospective investigation of comparative analysis with F-FDG.[F] AlF‑NOTA‑FAPI‑04 PET/CT 作为一种有前途的成像工具,用于胃肠道癌症中的成纤维细胞激活蛋白:与 F-FDG 比较分析的前瞻性研究。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4051-4063. doi: 10.1007/s00259-023-06351-9. Epub 2023 Aug 5.
7
Comparing the clinical value of baseline [ Ga]Ga-FAPI-04 PET/CT and [F]F-FDG PET/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis.对比基线 [68Ga]Ga-FAPI-04 PET/CT 和 [18F]F-FDG PET/CT 在胰腺导管腺癌中的临床价值:远端胰腺炎的附加预后价值。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4036-4050. doi: 10.1007/s00259-023-06297-y. Epub 2023 Jul 26.
8
FAPI PET/CT Imaging-An Updated Review.FAPI PET/CT成像——最新综述
Diagnostics (Basel). 2023 Jun 9;13(12):2018. doi: 10.3390/diagnostics13122018.
9
Advancements of molecular imaging and radiomics in pancreatic carcinoma.分子成像与放射组学在胰腺癌中的进展
World J Radiol. 2023 Jan 28;15(1):10-19. doi: 10.4329/wjr.v15.i1.10.
10
The Application of [Ga]-Labeled FAPI-04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient-Derived Orthotopic Xenograft Models.[Ga]-标记 FAPI-04 PET/CT 在患者来源的原位异种移植模型中用于胰腺癌细胞靶向和早期检测的应用。
Contrast Media Mol Imaging. 2022 Aug 5;2022:6596702. doi: 10.1155/2022/6596702. eCollection 2022.